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Vital hypothalamic neurons regulating hunger, wakefulness, reward-seeking, and body
weight are often defined by unique expression of hypothalamus-specific neuropeptides.
Gene-ablation studies show that some of these peptides, notably orexin/hypocretin
(hcrt/orx), are themselves critical for stable states of consciousness and metabolic health.
However, neuron-ablation studies often reveal more severe phenotypes, suggesting
key roles for co-expressed transmitters. Indeed, most hypothalamic neurons, including
hcrt/orx cells, contain fast transmitters glutamate and GABA, as well as several
neuropeptides. What are the roles and relations between different transmitters expressed
by the same neuron? Here, we consider signaling codes for releasing different
transmitters in relation to transmitter and receptor diversity in behaviorally defined,
widely projecting “peptidergic” neurons, such as hcrt/orx cells. We then discuss latest
optogenetic studies of endogenous transmitter release from defined sets of axons in
situ, which suggest that recently characterized vital peptidergic neurons [e.g., hcrt/orx,
proopiomelanocortin (POMC), and agouti-related peptide (AgRP) cells], as well as classical
modulatory neurons (e.g., dopamine and acetylcholine cells), all use fast transmitters
to control their postsynaptic targets. These optogenetic insights are complemented
by recent observations of behavioral deficiencies caused by genetic ablation of fast
transmission from specific neuropeptidergic and aminergic neurons. Powerful and
fast (millisecond-scale) GABAergic and glutamatergic signaling from neurons previously
considered to be primarily “modulatory” raises new questions about the roles of slower
co-transmitters they co-express.
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CO-TRANSMISSION ANDWIDELY PROJECTING NEURONS
COORDINATING VITAL BRAIN FUNCTIONS
Although neurons are often classified based on a neurotransmit-
ter they contain (e.g., “cholinergic” or “GABAergic” cells), most
if not all neurons contain—and use—more than one neurotrans-
mitter. Yet, the relative roles of these “co-transmitters,” or even
whether they are actually released together, are unclear in even the
oldest and most fundamental processes, such as sleep and feed-
ing behavior. An interesting example is offered by recent studies
of hypothalamic neurons that co-express neuropeptide Y (NPY)
and agouti-related peptide (AgRP), and whose electrical activ-
ity drives feeding (Aponte et al., 2011). Destruction of these cells
leads to starvation (Gropp et al., 2005; Luquet et al., 2005), which
has been attributed to loss of the neuropeptides that they con-
tain. However, while NPY and AgRP cause feeding and weight
gain when artificially infused into the brain, and their expres-
sion is regulated by body energy status, the weight loss seen when
NPY/AgRP cells are destroyed is recapitulated by targeted deletion
of their ability to release GABA, rather than NPY or AgRP (Tong
et al., 2008). Are NPY and AgRP, then, relatively minor modula-
tors of energy balance, while GABA is the “main” transmitter used
by NPY/AgRP cells to drive feeding and weight gain? This does
not appear to be the case, since when NPY/AgRP cell terminals
are selectively stimulated using optogenetics at a behaviorally cru-
cial projection site, the resulting feeding response can be strongly
inhibited by antagonists of either GABA or NPY receptors (Atasoy
et al., 2012). This illustrates that, in terms of translating the elec-
trical activity in the same set of axons to behavior, neuropeptides
and small molecule transmitters are not interchangeable and can
be equally essential. How they co-operate is a key unresolved
question.
The last decade brought about a revolution in our under-
standing of hypothalamic neurotransmitters underlying states
of consciousness and metabolic health. Several hypothalamus-
specific neuropeptides have been shown to be essential for normal
sleep-wake cycles and body weight. For example, the knockout
of hypocretin/orexin (hcrt/orx) produces narcolepsy (Chemelli
et al., 1999), making hcrt/orx the first peptide messenger known
to be essential for normal wakefulness and for environment-
appropriate switches in the states of consciousness in mammals
(De Lecea et al., 2006; Sakurai, 2007). Mutations in neuropeptide
precursors, such as proopiomelanocortin (POMC), have been
linked to obesity (Farooqi and O’Rahilly, 2006). Selective abla-
tion of small-molecule-mediated neurotransmission in geneti-
cally defined populations of neurons demonstrated that gluta-
mate release from ventromedial hypothalamic neurons is critical
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for preventing hypoglycemia (Tong et al., 2007), while GABA
release from leptin receptor neurons is critical for the anti-obesity
effects of leptin in the brain (Vong et al., 2011). Such impor-
tant genetic, pharmacological, and anatomical studies identify
cells and transmitters maintaining key aspects of health, but not
how they do it. For example, recent optogenetic work high-
lighted that different firing rates in the same population of
hypothalamic neuropeptidergic neurons can produce strikingly
different behaviors (Adamantidis et al., 2007; Aponte et al.,
2011). How does this link with the above-mentioned molecu-
lar knowledge? Many hypothalamic neurons regulating alertness
and metabolic health are widely projecting and contain several
neurotransmitters, but can it be assumed that they release all
their transmitters at all projection targets every time an action
potential is fired? This seems irrational, for example, because
these molecules may issue “contradictory orders” (e.g., excita-
tory hcrt/orx and inhibitory dynorphin co-expressed in hcrt/orx
cells, Chou et al., 2001). Furthermore, evidence from other sys-
tems indicates that this assumption is not safe. In contradiction
to a version of the “Dale’s principle” proposing that a neuron uses
the same transmitters at all its synapses, multiple neuropeptides
derived from a common precursor can be differentially pack-
aged and transported to different neuronal processes, suggesting
that neurons do not always release the same set of chemical
messengers from all their endings (Fisher et al., 1988; Sossin
et al., 1990). To add further complexity, the same stimulus can
have differential effect on the release of the same neuropep-
tide from different parts of the same neuron (Sabatier et al.,
2003).
The language of the brain is both chemical and electrical,
and to add the “how” dimension to the “what/where” knowl-
edge supplied by recent breakthroughs, causal links need to be
made between electrical activity and transmitter release at phys-
iologically defined sites. The aim of this review is to provide a
wide-ranging overview of key concepts relevant to such a broader
understanding, with selected examples from many fields of neu-
roscience, but with later emphasis on hypothalamic hcrt/orx
cells. We discuss complementary properties of different trans-
mitters and electrical codes for their release. Then, taking the
hcrt/orx neurons as an example, we consider what their neuro-
chemical and electrophysiological diversity may achieve. Finally,
we discuss recent insights from optogenetics—currently the only
technique that allows causal links to be made between axonal
electrical activity and neurotransmitter release. This review is
not intended to be exhaustive or comprehensive, and broader
aspects of neuropeptide transmission are covered in more detail
in other recent reviews (Van Den Pol, 2012). Our aim is to
integrate older concepts with new type of knowledge emerging
from modern genetic and optogenetic deconstruction of neu-
ral circuits. This is likely to be relevant to some of the most
frequent medical problems of today, such as disorders of sleep
and energy balance (Leger and Bayon, 2010; Lam and Leroith,
2012).
WHY HAVE MORE THAN TWO TRANSMITTERS?
Neuronal processing replies on co-operation of intrinsic electrical
activity generated by neurons independently of any input, and the
input signals they receive from one another (neurotransmitters)
and from other cells (hormones). Since synaptic inputs essentially
provide ON/OFF signals, onemay ask why it is necessary to spend
energy on making more than two neurotransmitters, one exci-
tatory and one inhibitory. Indeed, early evidence from hypotha-
lamic circuits shows that most synaptic activity is eliminated by
blocking glutamate and GABA receptors (Van Den Pol et al.,
1990; Van Den Pol, 2003).Why does the hypothalamus, and other
brain regions, contain dozens of peptide transmitters in addi-
tion to glutamate and GABA, especially considering that most, if
not all, of these peptidergic neurons are also capable of releas-
ing glutamate and/or GABA (Atasoy et al., 2008, 2012; Dicken
et al., 2012; Schöne et al., 2012)? As illustrated by clear behavioral
phenotypes of knockouts of hypothalamic neuropeptides such as
hcrt/orx (Chemelli et al., 1999) and melanin-concentrating hor-
mone (Shimada et al., 1998), peptides are clearly critical for vital
brain functions. Yet, it is unclear why neural processing requires
the many cellular actions of exogenously applied neuropeptides
that have been identified to-date (Van Den Pol, 2012).
What properties of neuropeptides add behaviorally essential
dimensions to signaling within neural circuits, and why cannot
these dimensions be provided by fast transmitters? An often-used
argument is that neuropeptides are more capable of prolonged
actions, due to their slower breakdown and higher receptor
affinity (Salio et al., 2006). However, this property is not funda-
mentally different from fast transmitters, which are also capable
of eliciting prolonged effects since, like neuropeptides, they can
affect neuronal activity long after their release, by binding to slow-
acting metabotropic receptors and/or by allowing calcium inflow
into the cell (e.g., during LTP; Nelson et al., 2003; Lisman et al.,
2012). Furthermore, through “asynchronous release,” even one
presynaptic spike may be capable of eliciting prolonged release,
and postsynaptic action, of fast neurotransmitters in vital brain
circuits (Atasoy et al., 2012). How neuropeptides complement or
facilitate such phenomena is unclear. Ample evidence, however,
suggests that presynaptic signaling codes for the release of small
molecule and neuropeptide transmitters may be different. This
may expand the dynamic range of neuronal signaling by allowing
small molecule transmitters to be released without presynapti-
cally colocalized neuropeptides, and neuropeptides to maintain
transmission when prolonged stimulation depletes the supply of
fast transmitters.
SYNAPTIC VOCABULARY: DIFFERENT NEURAL CODES FOR
DIFFERENT TRANSMITTERS
Although the small diameter (<1µm) of mammalian brain ter-
minals makes it difficult to study this issue directly, the release
of neuropeptides is thought to require a different type of axonal
firing code than that of small-molecule transmitters. High-
frequency firing, and/or burst firing, may be required to release
the neuropeptides, whereas small-molecule transmitters require
less intense electrical stimulation (Salio et al., 2006; Leng and
Ludwig, 2008; Van Den Pol, 2012). This is thought to be at least
in part related to different locations of the two types of transmit-
ters within the presynaptic terminal: glutamate/GABA in small
clear vesicles docked closely to the membrane, and peptides in
large dense-core vesicles further away from the membrane (Salio
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et al., 2006; Leng and Ludwig, 2008). Intermediate-size neuro-
transmitters, such as catecholamines, have been reported to be
located in both large dense-core vesicles (e.g., same vesicles as
NPY, De Rijk et al., 1992) and small clear vesicles (El Mestikawy
et al., 2011). Calcium is a key trigger for the release of both vesi-
cles, and the near-membrane co-localization of calcium channels
with the small vesicles, but not with large vesicles, is considered at
least in part responsible for the observation that the amino acid
transmitters are released by large local [calcium] elevations near
the calcium channels (like those produced by an action potential),
whereas neuropeptide release may require global [calcium] eleva-
tions in the terminal cytosol (Verhage et al., 1991; Van Den Pol,
2012). While the global [calcium] rise implicated in neuropep-
tide and catecholamine release may not have to reach the same
high levels as those implicated in amino acid release (Verhage
et al., 1991), the global [calcium] rise may require temporal sum-
mation of the effects of many action potentials. Indeed, at some
central synapses, as many as several hundred spikes have been
estimated to be needed on average to release a single neuropeptide
vesicle (Leng and Ludwig, 2008), whereas the release of small-
molecule transmitters such as glutamate can occur in response
to a single spike. No broad “rules” linking specific firing rates
with different types of transmitters have yet been formulated,
except it has been consistently reported that higher frequen-
cies and/or more prolonged stimulation are required to release
“larger” transmitters than “smaller” transmitters. Recent exam-
ples include GABA (<1Hz stimulation) and kisspeptin (5–10Hz
stimulation) release from anteroventral periventricular nucleus
(Liu et al., 2011), and the release of glutamate (single-spike)
vs. acetylcholine (>20Hz prolonged stimulation) from habenula
neurons (Ren et al., 2011).
What are the implications of these release requirements for
neural processing? Considering that higher spike frequencies can
be associated with higher failure rates of fast transmission (e.g.,
Schöne et al., 2012), do neuropeptides expand the dynamic range
of synapses in firing ranges where the fast transmitter release satu-
rates? This seems especially logical for slow behaviors such as sleep
and feeding, which—unlike, for example, sensory processing—do
not require millisecond-scale responsiveness to the environment,
but may require prolonged neural activity better sustained by
neuropeptides and/or intrinsically active neurons so often found
in hypothalamic circuits (Burdakov, 2005).
Although many neuropeptides have direct postsynaptic effects
onmembrane excitability, many authors caution that this “should
not perhaps be thought of as their main biological action” (Salio
et al., 2006), and that a conceptual framework that includes “pep-
tides as equal and independent transmitters should be replaced by
one where peptides are viewed as essential and important mod-
ulators of GABA and glutamate actions” (Van Den Pol, 2003).
Such views presumably stem from the well-documented presy-
naptic and/or non-electrophysiological (e.g., genomic) actions
of neuropeptides. Indeed, recent optogenetic studies of pep-
tidergic neurons, reviewed below, showed that these cells release
fast transmitters, but have not yet revealed significant postsy-
naptic electrical effects of endogenously released neuropeptides.
Specifically how this integrates into a coherent view of co-
transmission is currently unclear, but current hypotheses envision
neuropeptides as commitment signals functionally binding net-
works together over long time-scales, or in the words of Leng and
Ludwig, “public announcements” vs. “whispered messages” deliv-
ered by fast and brief-acting neurotransmitters (Leng and Ludwig,
2008).
Overall, the material reviewed in this section, together with
experiments highlighting the possibility of release of different
transmitters from different parts of the same neuron (Fisher et al.,
1988; Sossin et al., 1990; Sabatier et al., 2003), suggests that frame-
works for functional dissection of co-transmission in a neuronal
population should encompass at least three levels of analysis:
chemical, electrical, and anatomical. Below, we review selected
recent developments relating to these aspects of hcrt/orx circuits,
which continue to captivate the authors’ attention due to their
key role in maintaining sleep–wake cycles and metabolic health in
mammals.
INTRINSIC DIVERSITY WITHIN A CELL TYPE: EXAMPLE OF
HCRT/ORX NEURONS
ELECTROPHYSIOLOGICAL DIVERSITY OF HCRT/ORX CIRCUITS
Intrinsic firing “signatures” of neurons, which arise from different
complements and/or distributions of ion channels they express,
captivated neuroscientists for decades (Llinas, 1988; Mainen and
Sejnowski, 1996), and more recent studies show that variation
in intrinsic electrical properties within the same neuronal type
can predict circuit and behavioral function (Angelo et al., 2012).
When hcrt/orx neurons are examined with standard “electrical
fingerprinting” protocols, such asmembrane potential “rebound”
after artificially imposed hyperpolarization, two distinct electri-
cal classes emerge. “H type” hcrt/orx cells display hyperpolar-
ized post-inhibitory rebound whereas “D type” hcrt/orx cells
display depolarized post-inhibitory rebound, and the two cell
types can be confirmed to be distinct by formal cluster analysis
(Schöne et al., 2011). The two hcrt/orx cell types display dis-
tinct responses to physiological elevations in extracellular glucose
levels: in H hcrt/orx cells, glucose evokes sustained hyperpo-
larization thereby allowing these cells to function as possible
“glucostats” (sensors of absolute glucose levels), while D hcrt/orx
cells show only temporary hyperpolarization and thus may act
as adaptive sensors of trends in glucose levels (Williams et al.,
2008). The two cell types also differ in fast synaptic inputs they
receive, in particular the glutamatergic minis are larger and more
frequent in H hcrt/orx cells (Schöne et al., 2011), and may be dif-
ferentially affected in Huntington’s disease, with H hcrt/orx cells
experiencing an abnormally high glutamatergic drive (Williams
et al., 2011).
PROJECTIONS AND MORPHOLOGY OF HCRT/ORX NEURONS
The complexity and diversity of hcrt/orx neuron function is
reflected in their widespread axonal projections throughout the
brain, including key regions involved in the regulation of appetite,
addiction, anxiety and wakefulness (Peyron et al., 1998). Attempts
have been made to map these different functions to different
anatomical subpopulations of hcrt/orx neurons. Activation of
hcrt/orx neurons of the lateral parts (LH) of the hypothalamus
has been implicated in reward related behaviors, whereas activa-
tion of hcrt/orx neurons in perifornical and dorsomedial parts
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(PFA-DMH) of the hypothalamus has been implicated in arousal
(Harris and Aston-Jones, 2006). Indeed, topographically differ-
ent subsets of hcrt/orx cells may be quite differently regulated
by inputs (Fadel et al., 2002; Yoshida et al., 2006). While in the
mouse, the biophysically distinct D and H hcrt/orx neurons are
not exactly split between LH and PFA-DMHparts of the hypotha-
lamus, the ratio of D to H type hcrt/orx neurons is higher in the
PFA-DMH compared to the LH (Williams et al., 2008). However,
in the mouse, the projections from LH and PFA-DMH hcrt/orx
cells, and from H and D types of hcrt/orx cells, converge on
both the locus coeruleus and ventral tegmental area (Gonzalez
et al., 2012). This suggests, that at least in terms of those arousal
(locus coeruleus) and reward (ventral tegmental area)-regulating
regions, topographically similar hcrt/orx cells may control arousal
and reward in the mouse (Gonzalez et al., 2012) and rat (Fadel
et al., 2002; Espana et al., 2005).
Morphologically, H hcrt/orx cells have more complex den-
drites than D hcrt/orx cells, at least in young animals (Schöne
et al., 2011). However, in terms of number of dendric branch
points and overall tree complexity, the dendritic structure of
hcrt/orx cells is relatively simple compared to, for example, corti-
cal and cerebellar projection neurons, and resembles the simple
dendritic trees of other hypothalamic projections neurons and
midbrain dopamine neurons (Grace and Onn, 1989; Armstrong,
1995; Stern, 2001; Schöne et al., 2011). Interestingly, since H
hcrt/orx cells havemore complex dendrites and stronger synapses
than D hcrt/orx cells, and could thus comprise a preferential
source of neural input to the hcrt/orx system (Schöne et al.,
2011).
TRANSMITTERS AND RECEPTORS THAT DECODE ELECTRICAL
ACTIVITY IN HCRT/ORX AXONS
The firing rate of hcrt/orx neurons is causally linked to awakening
in a frequency-dependent manner, and this link is at least partly
dependent on the expression of hcrt/orx (Adamantidis et al.,
2007). However, apart from hcrt/orx peptides, the “hcrt/orx”
neurons express a multitude of other transmitters and signaling
molecules. These include the opioid peptide dynorphin (Chou
et al., 2001), galanin (Hakansson et al., 1999), prolactin (Risold
et al., 1999), and neuronal activity-regulated pentraxin (Reti et al.,
2002; Crocker et al., 2005). Furthermore, different proportions
of hcrt/orx cell bodies also have been found to express gluta-
matergic and GABAergic markers, which may suggests that not
all hcrt/orx neurons express the same set of transmitters (Rosin
et al., 2003; Torrealba et al., 2003; Harthoorn et al., 2005; Henny
et al., 2010). Co-expressed transmitters could be contained in
different vesicles or share the same vesicles. The later could
lead to “vesicular synergy,” a novel mechanism where the pres-
ence of transporters for one transmitter enhances the function
of transporters for the other transmitter, thereby increasing the
vesicular transmitter content (El Mestikawy et al., 2011). Whether
all transmitters expressed by a single hcrt/orx neuron all act at
all its projection targets cannot be predicted from immunocy-
tochemical or electron microscopy data available so far, in part
because the axons and terminals of a single neuron are difficult
to immuno-label and trace to postsynaptic partners (although
not impossible, Rancz et al., 2011), and partly because a proof
of “action” requires rapid functional assays at synaptic level (see
next section).
The trafficking and/or synthesis of transmitters expressed in
hcrt/orx may depend on target area and homeostatic state. This
is indicated by maximum hcrt/orx levels in preoptic/anterior
hypothalamus at the beginning of the light phase, but at the
beginning of the dark phase in pons (Taheri et al., 2000).
Levels of hcrt/orx in the cerebrospinal fluid levels are also high-
est at night (Fujiki et al., 2001), in line with maximal activ-
ity of hcrt/orx cells at this clocktime (Estabrooke et al., 2001;
Kiyashchenko et al., 2002; Lee et al., 2005; Mileykovskiy et al.,
2005). Similarly to hcrt/orx peptides, the levels of dynorphins
are also regulated throughout the circadian rhythm, with lev-
els increased during the active circadian phase or upon water
deprivation (Przewlocki et al., 1983). Thus, the strength of differ-
ent signaling molecules could vary differently depending on the
projection target, circadian time, or body homeostasis, leading
to corresponding changes in hcrt/orx cell signaling to postsy-
naptic targets. Important actions of non-hcrt/orx transmitters
expressed in hcrt/orx neurons may explain why the feeding,
body weight, and stress-induced thermogenesis abnormalities
of hcrt/orx cell-ablated mice are more severe than those in
hcrt/orx peptide-ablated mice (Hara et al., 2005; Zhang et al.,
2010).
Since the effects of neurotransmitters expressed in hcrt/orx
neurons are constrained by the availability of receptors, the dis-
tribution of receptors mediating hcrt/orx neuron signaling is
key to understanding target-specific action of hcrt/orx neurons.
The two known GPCRs for the hcrt/orx peptide show differ-
ential distribution, but partially overlap (reviewed in Sakurai,
2007). Dynorphin-containing fibers are found in most brain
regions containing hcrt/orx fibers, but because there are many
sources of dynorphin in the brain, it is currently unclear which
of these fibers come from hcrt/orx neurons (Fallon and Leslie,
1986). Bath application of neuropeptides such as hcrt/orx or
dynorphin revealed presynaptic effects on both GABAergic and
glutamatergic synaptic transmission, as well as direct postsy-
naptic actions on membrane excitability of target cells (Van
Den Pol et al., 1998; Burdakov, 2004). However, endogenously
released transmitters might have different concentrations and
time courses of action from those in artificial-application exper-
iments. Especially, since hcrt/orx neurons express more than
one transmitter, these will, when directly released from termi-
nals together with other endogenous signaling molecules, have
complex interactions and could activate multiple feedback mech-
anisms. There are currently no direct studies of this issue, but
there are interesting data from artificial co-application of dynor-
phin and hcrt/orx at different postsynaptic targets, showing
target-specific effects and different rates of desensitization for
the two peptides (Li and Van Den Pol, 2006). Release of gluta-
mate by hcrt/orx neurons, probed using optogenetics, is reviewed
separately below.
HOW DO NEUROCHEMISTRY, NEUROANATOMY, AND
ELECTROPHYSIOLOGY FIT TOGETHER?
How is signaling from endogenous hcrt/orx axons implemented
on the synaptic level at different targets? Theoretically, there are
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FIGURE 1 | Neurotransmission with multiple signaling molecules—a
combinatorial analysis. (A) When a certain cell type expresses multiple
transmitters, these may act differentially on specific targets with subgroups of
neurons expressing subsets of transmitters and modulating different target
areas. (B) However, multiple transmitters expressed in the same cell still may
affect their targets differentially. As illustrated in the top panel transmitters
may be targeted to different release sites or may need different activity
patterns (e.g., amino acid transmitters vs. neuropeptides). Middle panel: Even
though transmitters may be released at the same sites, postsynaptic receptor
expression or activity patterns may limit the action of one or the other
transmitter on the postsynaptic target. Bottom panel: Transmission can be
further altered and diversified by transmitter actions on presynaptic receptors.
many combinations of ways by which hcrt/orx neurons can influ-
ence their targets (Figure 1). Taken together, the high diversity
in the hcrt/orx system may be the key feature to enable these
neurons to differentially modulate their targets. These features
may be: (1) At the target: Multiple receptors at distinct pre- or
postsynaptic sites, with different affinities, and time-courses of
action, and (2) At the release site: Subsets of hcrt/orx neurons
expressing different sets of transmitters, projecting to different
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target areas, and distinct biophysical properties of these neurons,
as well as differential targeting of transmitters to different regions
of the brain at different times throughout the circadian rhythm to
allow hcrt/orx neurons to regulate arousal and appetite according
to homeostatic and environmental factors.
OPTOGENETICS REVEALS FAST TRANSMISSION FROM
CLASSICAL “SLOWMODULATORY” NEURONS
At present, optogenetics is the only technique that allows causal
links to be made between firing rates and transmitter release
from genetically defined sets of axons inside native brain net-
works (Gradinaru et al., 2010; Bernstein et al., 2011; Miesenbock,
2011). The selectivity and power of optogenetics stems from
genetic targeting of fast “light-switches” for neuronal activity,
and from the non-invasive nature of light used to control those
switches. Optogenetic tools can be used to manipulate the mem-
brane potential of cells on a millisecond timescale. This approach
uses light sensitive proteins such as excitatory channelrhodopsin-
2 which is an ion channel permeable to sodium, or inhibitory
chloride pump halorhodopsin (Figure 2A, top panel). There
is now a growing repertoire of light-sensitive proteins with
improved or novel functions, which are reviewed elsewhere
(Yizhar et al., 2011). They then can be used in genetically identi-
fied neurons to directly stimulate or inhibit action potential firing
in cell bodies or axons in vivo and in vitro.
Following the in vivo optogenetic demonstration that increases
in hcrt/orx cell firing rate can cause awakening (Adamantidis
et al., 2007), optogenetics has more recently been used to
investigate the endogenous synaptic transmission from hcrt/orx
neurons to their local-circuit partner, the histamine neu-
rons of the tuberomammilary hypothalamus. In this study,
channelrhodopsin-2 was targeted to hcrt/orx axons which were
then depolarized with millisecond precision to recreate the fir-
ing rates recorded from hcrt/orx cells in vivo, while using
membrane current and potential recordings from histamine
neurons as an endogenous “bioassay” to sense transmitters
released from hcrt/orx axons (Schöne et al., 2012). Stimulation
of channelrhodopsin-containing fibers withmillisecond flashes of
FIGURE 2 | Optogenetic tools for circuit mapping and functional
characterization of synaptic signaling modes. (A) Top panel: Example
of light activated excitatory and inhibitory optogenetic tools.
Channelrhodopsin 2 (ChR2) is a sodium channel sensitive to blue light.
Targeted to specific cell types it causes fast (millisecond scale)
depolarization and stimulation of action potentials in these cells.
Halorhodopsin (NpHR) is a light activated chloride pump which causes
hyperpolarization and suppression of action potential firing in target
neurons. Bottom and middle panel: Whole-cell recordings of an hcrt/orx
neuron expressing ChR2 before and during 20Hz optical stimulation (blue
bar). Bottom: Voltage clamp recording showing time locked currents
evoked by blue light flashes. Middle: Current clamp recording with
baseline firing rate and time locked action potential firing during optical
stimulation. (B) Top panel: Experimental scheme illustrating experimental
setup for ChR2-assisted circuit mapping. Yellow neuron, expressing ChR2,
will release signaling molecules after optical stimulation. Time locked
responses in postsynaptic cell (white) can be recorded using whole-cell
patch-clamping. In combination with pharmacological blockade this
technique allows the determination of receptors and transmitters involved.
Bottom and middle panel: Recordings of a histamine neuron responding
to 20Hz optogenetic stimulation of hcrt/orx fibers (blue bar). Bottom:
Voltage-clamp recording showing time locked postsynaptic currents
evoked by transmitters release from hcrt/orx terminals in response to blue
light flashes. Failures indicate that not all action potentials lead to vesicle
release. Middle: Current-clamp recording with baseline firing rate and
increased action potential firing during optical stimulation of hcrt/orx fibers.
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excitation light generated fast postsynaptic currents in his-
tamine neurons, with a high connection probability (Schöne
et al., 2012) (Figure 2B, top and bottom panel). These cur-
rents were completely abolished by blockade of AMPA-type
glutamate receptors. Furthermore, during brief (10 s) trains of
optogenetically induced spikes in hcrt/orx axons at physiologi-
cal firing frequencies, the glutamate inputs were necessary and
sufficient to translate the electrical activity in hcrt/orx axons
into increases in histamine cell firing (Schöne et al., 2012). This
suggests that, at least under brief-stimulation conditions, the
variations in electrical activity of endogenous hcrt/orx axons
can induce glutamate-driven changes in electrical signals gen-
erated by histamine neurons without a requirement for other
co-transmitters. It will be important to determine the role
of these findings in in vivo observations of striking instabil-
ity of consciousness caused by knockout of hcrt/orx peptides
or receptors (Chemelli et al., 1999; Mieda et al., 2011), espe-
cially if this leaves the glutamate release from hcrt/orx cells
unaltered.
Similar observations have recently been made during optoge-
netic probing of other neurons previously considered to commu-
nicate with their postsynaptic targets via the release of slow “mod-
ulatory” transmitters. For example, optogenetic stimulation of
arcuate hypothalamic neurons expressing diverse neuropeptides
derived from POMC leads to release and fast postsynaptic
actions of either glutamate or GABA (Dicken et al., 2012).
Optogenetic stimulations from neighboring feeding-promoting
neurons expressing neuropeptides AgRP and NPY results in post-
synaptic electrophysiological effects that are completely blocked
by GABA antagonists in at least some postsynaptic targets,
although both GABA and NPY signaling are necessary for the
stimulation of AgRP cell axons to be translated into feeding
(Atasoy et al., 2012). Classical “modulatory” neurons are no
exception: when optogenetically stimulated, axons of mesolimbic
dopamine neurons release glutamate in the nucleus accumbens
(Tecuapetla et al., 2010). In turn, habenula cholinergic neu-
rons release glutamate during brief optogenetic stimulation of
their axons, and release acetylcholine during stronger and more
prolonged stimulation (Ren et al., 2011).
Thus, recent evidence suggests that, at least at some of their
synapses, neuropeptidergic, cholinergic, and aminergic neurons
can use GABA or glutamate as primary fast neurotransmitters.
How it relates to the action of classical modulatory transmit-
ters they contain remains to be determined, but, considering that
neuropeptides and other slow transmitters may only be released
during intense activity, the ability of these neurons to release
fast transmitters from small vesicles would certainly expand
the dynamic range over which their firing can influence brain
function.
OVERVIEW: ROLES OF CO-TRANSMISSION AND
NEUROTRANSMITTER “IDENTITY CRISIS”
Powerful and fast (millisecond-scale) GABAergic and
glutamatergic signaling from neurons previously considered to
be primarily “modulatory” raises new questions about the roles
of slower co-transmitters they co-express. The behavioral roles
of this co-release remain poorly understood but are beginning
to be unraveled by cell-specific knockout of selected neurotrans-
mitters (Tong et al., 2007, 2008; Birgner et al., 2010; Alsio et al.,
2011), although the results of such studies may be affected by
developmental compensation in other neurotransmitters (e.g.,
knockout of NPY fromNPY/AgRP neurons enhances their GABA
transmission; Atasoy et al., 2012). Understanding circuit roles of
co-expressed transmitters needs to include site-specific infor-
mation about synaptic processing arrangements (Figure 1). This
requires temporarily and spatially precise control over the activity
of genetically specified synaptic terminals, which is now possi-
ble through optogenetics and/or modern spatial light patterning
(Lutz et al., 2008).
A further confounding factor is the recent doubt shed on
the idea that the neurotransmitter identity of a neuron remains
the same after proliferation throughout the rest of a neurons’
life. Activity-dependent re-specification of neurotransmitters has
become an emerging topic in the homeostatic control of brain
activity (Spitzer, 2012). Furthermore, the adult brain, and in
particular the hypothalamus, may have the capacity to re-wire
itself anatomically within hours (Horvath and Diano, 2004).
Such rapid rearrangements in brain chemistry and morphol-
ogy in response to experimental perturbations introduce uncer-
tainty into the extent to which the natural “rules” of brain
processing can be derived from slow and/or irreversible pertur-
bations offered by classical genetics. Optogenetics offers fast and
reversible ways of manipulating genetically defined pathways on
the millisecond time-scales at which brain processes information.
This could acheive greater certainty, especially when combined
with rapid and direct “read-out” techniques such as classical
electrophysiology. Such modern approaches may provide clearer
answers about why it is advantageous for the brain to invest
energy intomaking different classes of neurotransmitters and into
segregating or combining them together.
ACKNOWLEDGMENTS
Work in the authors’ laboratory is supported by ERC-FP7 starting
grant (to Denis Burdakov).
REFERENCES
Adamantidis, A. R., Zhang, F., Aravanis,
A. M., Deisseroth, K., and De
Lecea, L. (2007). Neural substrates
of awakening probed with optoge-
netic control of hypocretin neurons.
Nature 450, 420–424.
Alsio, J., Nordenankar, K., Arvidsson,
E., Birgner, C., Mahmoudi,
S., Halbout, B., et al. (2011).
Enhanced sucrose and cocaine
self-administration and cue-
induced drug seeking after loss of
VGLUT2 in midbrain dopamine
neurons in mice. J. Neurosci. 31,
12593–12603.
Angelo, K., Rancz, E. A., Pimentel,
D., Hundahl, C., Hannibal, J.,
Fleischmann, A., et al. (2012). A
biophysical signature of network
affiliation and sensory processing in
mitral cells. Nature 488, 375–378.
Aponte, Y., Atasoy, D., and Sternson, S.
M. (2011). AGRP neurons are suffi-
cient to orchestrate feeding behavior
rapidly and without training. Nat.
Neurosci. 14, 351–355.
Armstrong, W. E. (1995).
Morphological and electro-
physiological classification of
hypothalamic supraoptic neurons.
Prog. Neurobiol. 47, 291–339.
Atasoy, D., Aponte, Y., Su, H. H., and
Sternson, S. M. (2008). A FLEX
switch targets Channelrhodopsin-
2 to multiple cell types for imag-
ing and long-range circuit mapping.
J. Neurosci. 28, 7025–7030.
Atasoy, D., Betley, J. N., Su, H.
H., and Sternson, S. M. (2012).
Frontiers in Behavioral Neuroscience www.frontiersin.org November 2012 | Volume 6 | Article 81 | 7
Schöne and Burdakov Fast transmitters in slow behaviors
Deconstruction of a neural circuit
for hunger. Nature 488, 172–177.
Bernstein, J. G., Garrity, P. A., and
Boyden, E. S. (2011). Optogenetics
and thermogenetics: technologies
for controlling the activity of tar-
geted cells within intact neural cir-
cuits. Curr. Opin. Neurobiol. 22,
61–71.
Birgner, C., Nordenankar, K.,
Lundblad, M., Mendez, J. A., Smith,
C., Le Greves, M., et al. (2010).
VGLUT2 in dopamine neurons
is required for psychostimulant-
induced behavioral activation. Proc.
Natl. Acad. Sci. U.S.A. 107, 389–394.
Burdakov, D. (2004). Electrical signal-
ing in central orexin/hypocretin cir-
cuits: tuning arousal and appetite to
fit the environment. Neuroscientist
10, 286–291.
Burdakov, D. (2005). Unraveling
electrical signaling strategies in
hypothalamic feeding circuits.
Trends Endocrinol. Metab. 16,
202–203.
Chemelli, R. M., Willie, J. T., Sinton,
C. M., Elmquist, J. K., Scammell,
T., Lee, C., et al. (1999). Narcolepsy
in orexin knockout mice: molecular
genetics of sleep regulation. Cell 98,
437–451.
Chou, T. C., Lee, C. E., Lu, J., Elmquist,
J. K., Hara, J., Willie, J. T., et al.
(2001). Orexin (hypocretin) neu-
rons contain dynorphin. J. Neurosci.
21, RC168.
Crocker, A., Espana, R. A.,
Papadopoulou, M., Saper, C. B.,
Faraco, J., Sakurai, T., et al. (2005).
Concomitant loss of dynorphin,
NARP, and orexin in narcolepsy.
Neurology 65, 1184–1188.
De Lecea, L., Jones, B. E., Boutrel,
B., Borgland, S. L., Nishino, S.,
Bubser, M., et al. (2006). Addiction
and arousal: alternative roles of
hypothalamic peptides. J. Neurosci.
26, 10372–10375.
De Rijk, E. P., Van Strien, F. J.,
and Roubos, E. W. (1992).
Demonstration of coexisting
catecholamine (dopamine), amino
acid (GABA), and peptide (NPY)
involved in inhibition of melan-
otrope cell activity in Xenopus
laevis: a quantitative ultrastructural,
freeze-substitution immunocy-
tochemical study. J. Neurosci. 12,
864–871.
Dicken, M. S., Tooker, R. E., and
Hentges, S. T. (2012). Regulation of
GABA and glutamate release from
proopiomelanocortin neuron ter-
minals in intact hypothalamic net-
works. J. Neurosci. 32, 4042–4048.
El Mestikawy, S., Wallen-Mackenzie,
A., Fortin, G. M., Descarries, L.,
and Trudeau, L. E. (2011). From
glutamate co-release to vesicular
synergy: vesicular glutamate trans-
porters. Nat. Rev. Neurosci. 12,
204–216.
Espana, R. A., Reis, K. M., Valentino,
R. J., and Berridge, C. W. (2005).
Organization of hypocretin/orexin
efferents to locus coeruleus and
basal forebrain arousal-related
structures. J. Comp. Neurol. 481,
160–178.
Estabrooke, I. V., McCarthy, M. T., Ko,
E., Chou, T. C., Chemelli, R. M.,
Yanagisawa, M., et al. (2001). Fos
expression in orexin neurons varies
with behavioral state. J. Neurosci. 21,
1656–1662.
Fadel, J., Bubser, M., and Deutch,
A. Y. (2002). Differential activation
of orexin neurons by antipsychotic
drugs associated with weight gain.
J. Neurosci. 22, 6742–6746.
Fallon, J. H., and Leslie, F. M. (1986).
Distribution of dynorphin and
enkephalin peptides in the rat brain.
J. Comp. Neurol. 249, 293–336.
Farooqi, S., and O’Rahilly, S. (2006).
Genetics of obesity in humans.
Endocr. Rev. 27, 710–718.
Fisher, J. M., Sossin, W., Newcomb, R.,
and Scheller, R. H. (1988). Multiple
neuropeptides derived from a com-
mon precursor are differentially
packaged and transported. Cell 54,
813–822.
Fujiki, N., Yoshida, Y., Ripley, B.,
Honda, K., Mignot, E., and
Nishino, S. (2001). Changes in CSF
hypocretin-1 (orexin A) levels in
rats across 24 hours and in response
to food deprivation. Neuroreport
12, 993–997.
Gonzalez, J. A., Jensen, L. T., Fugger,
L., and Burdakov, D. (2012).
Convergent inputs from electrically
and topographically distinct orexin
cells to locus coeruleus and ventral
tegmental area. Eur. J. Neurosci. 35,
1426–1432.
Grace, A. A., and Onn, S. P. (1989).
Morphology and electrophysiologi-
cal properties of immunocytochem-
ically identified rat dopamine neu-
rons recorded in vitro. J. Neurosci. 9,
3463–3481.
Gradinaru, V., Zhang, F.,
Ramakrishnan, C., Mattis, J.,
Prakash, R., Diester, I., et al. (2010).
Molecular and cellular approaches
for diversifying and extending
optogenetics. Cell 141, 154–165.
Gropp, E., Shanabrough, M., Borok,
E., Xu, A. W., Janoschek, R.,
Buch, T., et al. (2005). Agouti-
related peptide-expressing neurons
are mandatory for feeding. Nat.
Neurosci. 8, 1289–1291.
Hakansson, M., De Lecea, L., Sutcliffe,
J. G., Yanagisawa, M., and Meister,
B. (1999). Leptin receptor- and
STAT3-immunoreactivities in
hypocretin/orexin neurones
of the lateral hypothalamus.
J. Neuroendocrinol. 11, 653–663.
Hara, J., Yanagisawa, M., and Sakurai,
T. (2005). Difference in obesity phe-
notype between orexin-knockout
mice and orexin neuron-deficient
mice with same genetic background
and environmental conditions.
Neurosci. Lett. 380, 239–242.
Harris, G. C., and Aston-Jones, G.
(2006). Arousal and reward: a
dichotomy in orexin function.
Trends Neurosci. 29, 571–577.
Harthoorn, L. F., Sane, A., Nethe, M.,
and Van Heerikhuize, J. J. (2005).
Multi-transcriptional profiling of
melanin-concentrating hormone
and orexin-containing neurons.
Cell. Mol. Neurobiol. 25, 1209–1223.
Henny, P., Brischoux, F., Mainville,
L., Stroh, T., and Jones, B. E.
(2010). Immunohistochemical evi-
dence for synaptic release of gluta-
mate from orexin terminals in the
locus coeruleus. Neuroscience 169,
1150–1157.
Horvath, T. L., and Diano, S. (2004).
The floating blueprint of hypotha-
lamic feeding circuits. Nat. Rev.
Neurosci. 5, 662–667.
Kiyashchenko, L. I., Mileykovskiy, B. Y.,
Maidment, N., Lam, H. A., Wu, M.
F., John, J., et al. (2002). Release
of hypocretin (orexin) during wak-
ing and sleep states. J. Neurosci. 22,
5282–5286.
Lam, D.W., and Leroith, D. (2012). The
worldwide diabetes epidemic. Curr.
Opin. Endocrinol. Diabetes Obes. 19,
93–96.
Lee, M. G., Hassani, O. K., and Jones,
B. E. (2005). Discharge of identified
orexin/hypocretin neurons across
the sleep-waking cycle. J. Neurosci.
25, 6716–6720.
Leger, D., and Bayon, V. (2010). Societal
costs of insomnia. Sleep Med. Rev.
14, 379–389.
Leng, G., and Ludwig, M. (2008).
Neurotransmitters and peptides:
whispered secrets and public
announcements. J. Physiol. 586,
5625–5632.
Li, Y., and Van Den Pol, A. N.
(2006). Differential target-
dependent actions of coexpressed
inhibitory dynorphin and excitatory
hypocretin/orexin neuropeptides.
J. Neurosci. 26, 13037–13047.
Lisman, J., Yasuda, R., and
Raghavachari, S. (2012).
Mechanisms of CaMKII action
in long-term potentiation. Nat. Rev.
Neurosci. 13, 169–182.
Liu, X., Porteous, R., D’Anglemont De
Tassigny, X., Colledge, W. H., Millar,
R., Petersen, S. L., et al. (2011).
Frequency-dependent recruitment
of fast amino acid and slow neu-
ropeptide neurotransmitter release
controls gonadotropin-releasing
hormone neuron excitability.
J. Neurosci. 31, 2421–2430.
Llinas, R. R. (1988). The intrinsic
electrophysiological properties of
mammalian neurons: insights into
central nervous system function.
Science 242, 1654–1664.
Luquet, S., Perez, F. A., Hnasko, T.
S., and Palmiter, R. D. (2005).
NPY/AgRP neurons are essential for
feeding in adult mice but can be
ablated in neonates. Science 310,
683–685.
Lutz, C., Otis, T. S., Desars, V., Charpak,
S., Digregorio, D. A., and Emiliani,
V. (2008). Holographic photolysis
of caged neurotransmitters. Nat.
Methods 5, 821–827.
Mainen, Z. F., and Sejnowski, T. J.
(1996). Influence of dendritic struc-
ture on firing pattern in model
neocortical neurons. Nature 382,
363–366.
Mieda, M., Hasegawa, E., Kisanuki, Y.
Y., Sinton, C. M., Yanagisawa, M.,
and Sakurai, T. (2011). Differential
roles of orexin receptor-1 and -
2 in the regulation of non-REM
and REM sleep. J. Neurosci. 31,
6518–6526.
Miesenbock, G. (2011). Optogenetic
control of cells and circuits. Annu.
Rev. Cell Dev. Biol. 27, 731–758.
Mileykovskiy, B. Y., Kiyashchenko, L. I.,
and Siegel, J. M. (2005). Behavioral
correlates of activity in identified
hypocretin/orexin neurons. Neuron
46, 787–798.
Nelson, A. B., Krispel, C. M., Sekirnjak,
C., and Du Lac, S. (2003). Long-
lasting increases in intrinsic
excitability triggered by inhibition.
Neuron 40, 609–620.
Peyron, C., Tighe, D. K., Van Den
Pol, A. N., De Lecea, L., Heller,
H. C., Sutcliffe, J. G., et al. (1998).
Neurons containing hypocretin
(orexin) project to multiple neu-
ronal systems. J. Neurosci. 18,
9996–10015.
Przewlocki, R., Lason, W., Konecka, A.
M., Gramsch, C., Herz, A., and Reid,
L. D. (1983). The opioid peptide
dynorphin, circadian rhythms, and
starvation. Science 219, 71–73.
Rancz, E. A., Franks, K. M., Schwarz,
M. K., Pichler, B., Schaefer, A.
T., and Margrie, T. W. (2011).
Transfection via whole-cell record-
ing in vivo: bridging single-cell
physiology, genetics and connec-
tomics. Nat. Neurosci. 14, 527–532.
Ren, J., Qin, C., Hu, F., Tan, J.,
Qiu, L., Zhao, S., et al. (2011).
Frontiers in Behavioral Neuroscience www.frontiersin.org November 2012 | Volume 6 | Article 81 | 8
Schöne and Burdakov Fast transmitters in slow behaviors
Habenula “cholinergic” neurons co-
release glutamate and acetylcholine
and activate postsynaptic neurons
via distinct transmission modes.
Neuron 69, 445–452.
Reti, I. M., Reddy, R., Worley, P. F.,
and Baraban, J. M. (2002). Selective
expression of Narp, a secreted neu-
ronal pentraxin, in orexin neurons.
J. Neurochem. 82, 1561–1565.
Risold, P. Y., Griffond, B., Kilduff, T.
S., Sutcliffe, J. G., and Fellmann, D.
(1999). Preprohypocretin (orexin)
and prolactin-like immunoreactiv-
ity are coexpressed by neurons of
the rat lateral hypothalamic area.
Neurosci. Lett. 259, 153–156.
Rosin, D. L., Weston, M. C., Sevigny,
C. P., Stornetta, R. L., and Guyenet,
P. G. (2003). Hypothalamic orexin
(hypocretin) neurons express
vesicular glutamate transporters
VGLUT1 or VGLUT2. J. Comp.
Neurol. 465, 593–603.
Sabatier, N., Caquineau, C., Dayanithi,
G., Bull, P., Douglas, A. J., Guan,
X. M., et al. (2003). Alpha-
melanocyte-stimulating hormone
stimulates oxytocin release from
the dendrites of hypothalamic
neurons while inhibiting oxytocin
release from their terminals in the
neurohypophysis. J. Neurosci. 23,
10351–10358.
Sakurai, T. (2007). The neural circuit
of orexin (hypocretin): maintain-
ing sleep and wakefulness. Nat. Rev.
Neurosci. 8, 171–181.
Salio, C., Lossi, L., Ferrini, F., and
Merighi, A. (2006). Neuropeptides
as synaptic transmitters. Cell Tissue
Res. 326, 583–598.
Schöne, C., Cao, Z., Apergis-Schoute,
J., Adamantidis, A., Sakurai, T., and
Burdakov, D. (2012). Optogenetic
probing of fast glutamatergic trans-
mission from hypocretin/orexin
to histamine neurons in situ.
J. Neurosci. 32, 12437–12443.
Schöne, C., Venner, A., Knowles, D.,
Karnani, M. M., and Burdakov, D.
(2011). Dichotomous cellular prop-
erties of mouse orexin/hypocretin
neurons. J. Physiol. 589, 2767–2779.
Shimada, M., Tritos, N. A., Lowell,
B. B., Flier, J. S., and Maratos-
Flier, E. (1998). Mice lacking
melanin-concentrating hormone
are hypophagic and lean. Nature
396, 670–674.
Sossin, W. S., Sweet-Cordero, A.,
and Scheller, R. H. (1990). Dale’s
hypothesis revisited: different neu-
ropeptides derived from a common
prohormone are targeted to differ-
ent processes. Proc. Natl. Acad. Sci.
U.S.A. 87, 4845–4848.
Spitzer, N. C. (2012). Activity-
dependent neurotransmitter
respecification. Nat. Rev. Neurosci.
13, 94–106.
Stern, J. E. (2001). Electrophysiological
and morphological properties of
pre-autonomic neurones in the
rat hypothalamic paraventricular
nucleus. J. Physiol. 537, 161–177.
Taheri, S., Sunter, D., Dakin, C., Moyes,
S., Seal, L., Gardiner, J., et al.
(2000). Diurnal variation in orexin
A immunoreactivity and prepro-
orexin mRNA in the rat central
nervous system. Neurosci. Lett. 279,
109–112.
Tecuapetla, F., Patel, J. C., Xenias, H.,
English, D., Tadros, I., Shah, F., et al.
(2010). Glutamatergic signaling by
mesolimbic dopamine neurons in
the nucleus accumbens. J. Neurosci.
30, 7105–7110.
Tong, Q., Ye, C., McCrimmon, R. J.,
Dhillon, H., Choi, B., Kramer, M.
D., et al. (2007). Synaptic glutamate
release by ventromedial hypothala-
mic neurons is part of the neurocir-
cuitry that prevents hypoglycemia.
Cell Metab. 5, 383–393.
Tong, Q., Ye, C. P., Jones, J. E., Elmquist,
J. K., and Lowell, B. B. (2008).
Synaptic release of GABA by AgRP
neurons is required for normal
regulation of energy balance. Nat.
Neurosci. 11, 998–1000.
Torrealba, F., Yanagisawa, M., and
Saper, C. B. (2003). Colocalization
of orexin a and glutamate
immunoreactivity in axon ter-
minals in the tuberomammillary
nucleus in rats. Neuroscience 119,
1033–1044.
Van Den Pol, A. N. (2003). Weighing
the role of hypothalamic feed-
ing neurotransmitters. Neuron 40,
1059–1061.
Van Den Pol, A. N. (2012).
Neuropeptide transmission in
brain circuits. Neuron 76, 98–115.
Van Den Pol, A. N., Gao, X. B.,
Obrietan, K., Kilduff, T. S., and
Belousov, A. B. (1998). Presynaptic
and postsynaptic actions and mod-
ulation of neuroendocrine neurons
by a new hypothalamic peptide,
hypocretin/orexin. J. Neurosci. 18,
7962–7971.
Van Den Pol, A. N., Wuarin, J.
P., and Dudek, F. E. (1990).
Glutamate, the dominant
excitatory transmitter in neu-
roendocrine regulation. Science 250,
1276–1278.
Verhage, M., McMahon, H. T., Ghijsen,
W. E., Boomsma, F., Scholten,
G., Wiegant, V. M., et al. (1991).
Differential release of amino acids,
neuropeptides, and catecholamines
from isolated nerve terminals.
Neuron 6, 517–524.
Vong, L., Ye, C., Yang, Z., Choi, B.,
Chua, S. Jr., and Lowell, B. B.
(2011). Leptin action on GABAergic
neurons prevents obesity and
reduces inhibitory tone to POMC
neurons. Neuron 71, 142–154.
Williams, R. H., Alexopoulos, H.,
Jensen, L. T., Fugger, L., and
Burdakov, D. (2008). Adaptive
sugar sensors in hypothalamic
feeding circuits. Proc. Natl. Acad.
Sci. U.S.A. 105, 11975–11980.
Williams, R. H., Morton, A. J., and
Burdakov, D. (2011). Paradoxical
function of orexin/hypocretin
circuits in a mouse model of
Huntington’s disease. Neurobiol.
Dis. 42, 438–455.
Yizhar, O., Fenno, L. E., Davidson, T.
J., Mogri, M., and Deisseroth, K.
(2011). Optogenetics in neural sys-
tems. Neuron 71, 9–34.
Yoshida, K., McCormack, S., Espana,
R. A., Crocker, A., and Scammell,
T. E. (2006). Afferents to the orexin
neurons of the rat brain. J. Comp.
Neurol. 494, 845–861.
Zhang, W., Sunanaga, J., Takahashi,
Y., Mori, T., Sakurai, T., Kanmura,
Y., et al. (2010). Orexin neurons
are indispensable for stress-induced
thermogenesis in mice. J. Physiol.
588, 4117–4129.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 31 August 2012; accepted: 05
November 2012; published online: 26
November 2012.
Citation: Schöne C and Burdakov D
(2012) Glutamate and GABA as rapid
effectors of hypothalamic “peptidergic”
neurons. Front. Behav. Neurosci. 6:81.
doi: 10.3389/fnbeh.2012.00081
Copyright © 2012 Schöne and
Burdakov. This is an open-access
article distributed under the terms of the
Creative Commons Attribution License,
which permits use, distribution and
reproduction in other forums, provided
the original authors and source are
credited and subject to any copyright
notices concerning any third-party
graphics etc.
Frontiers in Behavioral Neuroscience www.frontiersin.org November 2012 | Volume 6 | Article 81 | 9
